A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 377
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : WHV
Long Form : woodchuck hepatitis virus
No. Year Title Co-occurring Abbreviation
2020 Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon-alpha in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus. ETV, HBsAg, HBV, PBMCs, pgRNA, wIFN-alpha
2020 Kinetics of DNA damage repair response accompanying initial hepadnavirus-host genomic integration in woodchuck hepatitis virus infection of hepatocyte. HBV, HO-1, NHEJ, p.i, PARP1, ROS, XRCC1
2020 Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B. CHB, HBV, PBMC, TFH, TLR8, WHsAg
2019 Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks. AHB, HBV, NK
2019 Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus. CHB, ETV, HBV, PK/PD, TLR7
2019 Structural Differences between the Woodchuck Hepatitis Virus Core Protein in the Dimer and Capsid States Are Consistent with Entropic and Conformational Regulation of Assembly. CP, cryo-EM, HBV
2018 Chinese woodchucks with different susceptibility to WHV infection differ in their genetic background exemplified by cytochrome B and MHC-DRB molecules. WHcAb, WHsAg
2018 Differential Expression of Woodchuck Toll-Like Receptors 1-10 in Distinct Forms of Infection and Stages of Hepatitis in Experimental Hepatitis B Virus Infection. AH, CH, HBV, PBMC, TLRs
2018 In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine. DHBV, DoG
10  2018 Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection. alphaPD-L1, CHB, ETV, HBV, IFN-gamma, PD-1, PD-L1, sAg
11  2017 Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks. ETV, IFN, NOD2
12  2017 Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma. HBV, HCC
13  2017 Measurement of Antiviral Effect and Innate Immune Response During Treatment of Primary Woodchuck Hepatocytes. HBV, PWHs
14  2017 Molecular cloning, characterization and expression analysis of Tim-3 and Galectin-9 in the woodchuck model. CDS, Gal-9, Tim-3
15  2017 PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB/c Mouse Model. HBV, HI, vDNA
16  2017 Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes. HBV, HCC
17  2016 Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B. HBV, IFN, NOD2
18  2016 Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-kappaB signaling and tumor progression in a woodchuck hepatocellular carcinoma model. HBV, HCC, MTA1, WHx, wk-MTA1
19  2016 Charge Detection Mass Spectrometry Identifies Preferred Non-Icosahedral Polymorphs in the Self-Assembly of Woodchuck Hepatitis Virus Capsids. CDMS, mass-to-charge
20  2016 Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection. AST, ETV, IFN, ODNs, PBMCs, WHsAg
21  2016 Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV). CDSs, HBV
22  2016 Molecular cloning, characterization and expression analysis of TGF-beta and receptor genes in the woodchuck model. CDS, HBV, TGF-beta
23  2016 Molecular cloning, characterization and expression analysis of woodchuck retinoic acid-inducible gene I. CARDs, CDSs, dsRNA, HBV, IFN-beta, pI, RD, RIG-I, siRNA, wRIG-I
24  2016 Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus. HBVs, HDV
25  2016 Transcriptome Analysis and Comparison of Marmota monax and Marmota himalayana. CDS, HBV, HCC, SNPs, SSRs
26  2015 AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B. ---
27  2015 Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection. HBV, HCC, OBI, POI, SOI
28  2015 Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks. ---
29  2015 Characterization and genotyping of the DRB1 gene of the major histocompatibility complex (MHC) in the Marmota monax, animal model of hepatitis B. ABS, MHC
30  2015 Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection. HCC
31  2015 Intrahepatic Transcriptional Signature Associated with Response to Interferon-alpha Treatment in the Woodchuck Model of Chronic Hepatitis B. CHB, HBV, IFN-alpha, ISGs, wIFN-alpha
32  2015 Persistence of the recombinant genomes of woodchuck hepatitis virus in the mouse model. HBsAg, HBV, HI
33  2015 Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7. HBV, HCCs
34  2015 Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B. CHB, HBV, HCC, WHsAg
35  2015 The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection. PD-1
36  2015 Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects. ---
37  2015 Woodchuck hepatitis virus core gene deletions and proliferative responses of peripheral blood mononuclear cells stimulated by an immunodominant epitope: a viral immune escape in the woodchuck model of chronic hepatitis B? aa, HBV, HCC
38  2014 Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection. ETV, HBV, PD-1, PD-L1
39  2014 Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins. ELISAs, Tg
40  2014 Nucleoside analogues alone or combined with vaccination prevent hepadnavirus viremia and induce protective immunity: alternative strategy for hepatitis B virus post-exposure prophylaxis. ETV, HBV, NAs, PEP
41  2014 Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B. HCC, POI
42  2014 Structurally similar woodchuck and human hepadnavirus core proteins have distinctly different temperature dependences of assembly. cryo-EM, HBV
43  2014 Variability in the precore and core promoter region of the hepatitis B virus genome. HBV, PCR
44  2013 Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model. AdV, ETV, HBV
45  2013 Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma. HBV, HCC, MMPs
46  2013 Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B. HBV, IFN-gamma, ISG
47  2013 Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7. CMV, HTNV, IFN, NP
48  2013 Possible origins and evolution of the hepatitis B virus (HBV). DHBV, HBV
49  2013 Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus. HBV, HDV
50  2013 Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis. HBV
51  2013 RNAi induces innate immunity through multiple cellular signaling pathways. ISGs, PMHs, RNAi, Tg
52  2013 Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. DHBV, HBV, pegIFN-alpha, pgRNA, SBA
53  2012 DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model. AdVs, HBV
54  2012 Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks. HBV, HCC, HDV, wHDV
55  2012 Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B. FOXP3, HBV, IL, TGF-beta
56  2012 Molecular characterization of the type I IFN receptor in two woodchuck species and detection of its expression in liver samples from woodchucks infected with woodchuck hepatitis virus (WHV). HBV
57  2012 Molecular characterization of woodchuck interleukin-10 receptor and enhanced function of specific T cells from chronically infected woodchucks following its blockade. HBV, IL-10, wIL-10R
58  2012 Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. HBV, PBMCs, TLR2
59  2012 Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein. HBV, HCC, Plk1, pX
60  2012 Transcriptomic analysis of the woodchuck model of chronic hepatitis B. CHB, HBV, HCC, SOCS3
61  2011 Characterization of woodchuck apolipoprotein A-I: a new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model. apoA-I, HCC, HDL, ORF
62  2011 Development of an animal model for radiofrequency ablation of primary, virally induced hepatocellular carcinoma in the woodchuck. HCC, MR, RF
63  2011 Disturbances in the glutathione/ophthalmate redox buffer system in the woodchuck model of hepatitis virus-induced hepatocellular carcinoma. HCC, OA, RBC
64  2011 Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks. EP, HBV, pDNA
65  2011 Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection. HBV
66  2011 The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. HBV, HBx
67  2011 The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection. HBV, IFN, PBMCs, PD-1, PD-L1, PWH, RT, TLR, wPD-L1
68  2010 Experimental Helicobacter marmotae infection in A/J mice causes enterohepatic disease. p.i
69  2010 Hepadnaviral infection augments hepatocyte cytotoxicity mediated by both CD95 ligand and perforin pathways. CD95L
70  2010 Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice. HBV
71  2010 Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis B. HBV
72  2010 The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies. ---
73  2010 The woodchuck: a model for therapeutic vaccination against hepadnaviral infection. HBV
74  2009 Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection. anti-WHs, CICs, SDH, WHsAg
75  2009 Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression. siRNA
76  2009 Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways. IFN, LPS, PWHs, TLR
77  2009 Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection. IL-12, POI
78  2009 Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B. HBV
79  2009 Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma. HCC, SFV
80  2009 The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. cccDNA, ETV
81  2009 Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12. IL-12, vg
82  2008 Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection. ---
83  2008 Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. ADV, HBV, TDF
84  2008 Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens. EP, HBV, IM, WHsAg
85  2008 Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis. HDV
86  2008 Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes. IFN, PBLs, wIFN-alpha
87  2008 Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus. HBV, HDV, hHDV, PHH, PWH
88  2008 Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity. ---
89  2008 Serologic survey of woodchuck hepatitis virus in North Carolina woodchucks (Marmota monax). ---
90  2007 Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide. CTL
91  2007 Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection. APD, DXG, HBV
92  2007 Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. HBV, WHc, wIFN-gamma
93  2007 Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein. CLV, HBV
94  2007 Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. CLV, HBV, PBS, TDF, Tet
95  2007 Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model. ---
96  2007 Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection. HBV, PBMCs
97  2007 Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins. 1-DNJ, BVDV, GBV-B, HBV
98  2007 The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology. FAH, PAS
99  2007 The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. HBV
100  2007 Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model. HBV